FDA 483 - Antarma LLC - September 23, 2022

Antarma LLC, a specification developer in New York, NY, was inspected by the FDA from September 22-23, 2022. The inspection resulted in one observation regarding inadequate procedures for ensuring purchased products and services conform to specified requirements. Specifically, the firm failed to qualify a contractor performing testing on suture devices and lacked an agreement for supplier change notification.